Propose un traitement innovant plus souple aux diabétiques de type 2, plus efficace et avec moins d’effets secondaires.
Location: France, Grand Est, Illkirch-Graffenstaden
Investors 2
| Date | Name | Website |
| 24.04.2023 | Capital Gr... | capitalgra... |
| - | Good Growt... | goodgrowth... |
Mentions in press and media 3
| Date | Title | Description |
| 12.11.2024 | AdipoPharma Raises Funding | AdipoPharma, a Strasbourg, France-based biotech company developing a novel and promising Type 2 diabetes drug, raised an undisclosed amount in funding. Backers included Newton Biocapital, Sambrinvest, Investsud, Okeanos, and dGood Growth Ca... |
| 30.01.2023 | 50 recently-funded startups to watch in 2023 | With the ongoing economic downturn and fear of a recession, tech startups have been hit hard as investors pulled back from new venture deals and reduce their investment in startups with exposure to recession. Further expounding on the fundi... |
| 23.01.2023 | AdipoPharma Raises Series A Funding | AdipoPharma, a Strasbourg, France-based biotech company developing a novel and promising type 2 diabetes drug, raised an undisclosed amount in Series A funding. The round was led by Newton Biocapital II, joined by Good Growth Capital of Cha... |